Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid Disorders

This study has been completed.
Immunex Corporation
Information provided by:
Amgen Identifier:
First received: August 19, 2005
Last updated: January 20, 2011
Last verified: January 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2004
  Primary Completion Date: February 2004 (Final data collection date for primary outcome measure)